{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:58:18Z","timestamp":1772557098210,"version":"3.50.1"},"reference-count":121,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.intimp.2004.05.020","type":"journal-article","created":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T17:35:57Z","timestamp":1087580157000},"page":"1135-1148","source":"Crossref","is-referenced-by-count":14,"title":["Herpesviral Fc\u03b3 receptors: culprits attenuating antiviral IgG?"],"prefix":"10.1016","volume":"4","author":[{"given":"Matthias","family":"Budt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrike","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Bigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2004.05.020_BIB1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/jinf.2001.0948","article-title":"Latency and reactivation of human cytomegalovirus","volume":"44","author":"Sissons","year":"2002","journal-title":"J. Infect."},{"key":"10.1016\/j.intimp.2004.05.020_BIB2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1750-3639.2001.tb00415.x","article-title":"Human herpesvirus latency","volume":"11","author":"Cohrs","year":"2001","journal-title":"Brain Pathol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.1999.tb01289.x","article-title":"Varicella-zoster virus immune evasion","volume":"168","author":"Abendroth","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2004.05.020_BIB4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0966-842X(98)01255-4","article-title":"Immune evasion by cytomegalovirus-survival strategies of a highly adapted opportunist","volume":"6","author":"Hengel","year":"1998","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB5","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.188.6.1047","article-title":"Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection","volume":"188","author":"Polic","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB6","series-title":"Fields virology","first-page":"2381","article-title":"The family herpesviridae: a brief introduction","author":"Roizman","year":"2001"},{"key":"10.1016\/j.intimp.2004.05.020_BIB7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(01)79001-3","article-title":"Neutralizing antiviral antibody responses","volume":"79","author":"Zinkernagel","year":"2001","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.18709-0","article-title":"Virus complement evasion strategies","volume":"84","author":"Favoreel","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-065X.1997.tb01007.x","article-title":"Complement and immunity to viruses","volume":"159","author":"Lachmann","year":"1997","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2004.05.020_BIB10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0161-5890(01)00047-5","article-title":"Membrane-targeted complement inhibitors","volume":"38","author":"Smith","year":"2001","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB11","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/eji.1830260719","article-title":"Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells","volume":"26","author":"Spiller","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB12","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.4049\/jimmunol.155.9.4376","article-title":"Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia\/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV)","volume":"155","author":"Spear","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(02)00369-2","article-title":"Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection","volume":"17","author":"Kapadia","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2004.05.020_BIB14","first-page":"1","article-title":"Neutralization of animal viruses","volume":"183","author":"Dimmock","year":"1993","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB15","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1128\/JVI.65.12.7046-7050.1991","article-title":"Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity","volume":"65","author":"Dubin","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0966-842X(02)02393-4","article-title":"Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion","volume":"10","author":"Mocarski","year":"2002","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/smim.2001.0294","article-title":"Immune evasion by human cytomegalovirus: lessons in immunology and cell biology","volume":"13","author":"Loenen","year":"2001","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1099\/0022-1317-58-2-373","article-title":"Studies on the mechanism of neutralization of influenza virus by antibody: evidence that neutralizing antibody (anti-haemagglutinin) inactivates influenza virus in vivo by inhibiting virion transcriptase activity","volume":"58","author":"Possee","year":"1982","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-2776(01)77018-6","article-title":"The antiviral activity of antibodies in vitro and in vivo","volume":"77","author":"Parren","year":"2001","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000319346","article-title":"Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy","volume":"65","author":"Parren","year":"1997","journal-title":"Chem. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB21","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.4049\/jimmunol.154.8.3975","article-title":"Protection from lethal coronavirus infection by immunoglobulin fragments","volume":"154","author":"Lamarre","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0161-5890(01)00119-5","article-title":"Antibody-mediated neutralization of cytomegalovirus: modulation of efficacy induced through the IgG constant region","volume":"38","author":"Furebring","year":"2002","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60486-1","article-title":"Human antibody effector function","volume":"51","author":"Burton","year":"1992","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB24","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1128\/JVI.71.8.5742-5749.1997","article-title":"Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding","volume":"71","author":"de Parseval","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB25","first-page":"65","article-title":"Growth, spread, and extracellular localization of herpes simplex virus 1 in Vero cells in the presence of an anti-gD plaque inhibiting monoclonal antibody","volume":"21","author":"Mannini-Palenzona","year":"1998","journal-title":"New Microbiol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB26","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1084\/jem.188.7.1223","article-title":"Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium","volume":"188","author":"Fujioka","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1074-7613(00)80610-X","article-title":"Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM","volume":"9","author":"Bomsel","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2004.05.020_BIB28","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB29","article-title":"Evidence of CMV-reinfection in a sero-positive host","author":"Strelow","year":"2003"},{"key":"10.1016\/j.intimp.2004.05.020_BIB30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1098\/rstb.2000.0786","article-title":"Dissecting the host response to a gamma-herpesvirus","volume":"356","author":"Doherty","year":"2001","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.intimp.2004.05.020_BIB31","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1084\/jem.179.5.1713","article-title":"Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus","volume":"179","author":"Jonjic","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1053\/spid.2002.125863","article-title":"Development of cytomegalovirus vaccines: prospects for prevention of congenital CMV infection","volume":"13","author":"Pass","year":"2002","journal-title":"Semin. Pediatr. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.05.020_BIB33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/095632029901000501","article-title":"Human cytomegalovirus: challenges, opportunities and new drug development","volume":"10","author":"Field","year":"1999","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.intimp.2004.05.020_BIB34","first-page":"353","article-title":"Cytomegalovirus pneumonia","volume":"14","author":"Salomon","year":"1999","journal-title":"Semin. Respir. Infect."},{"key":"10.1016\/j.intimp.2004.05.020_BIB35","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-3542(00)00111-X","article-title":"Antibodies for the prevention and treatment of viral diseases","volume":"47","author":"Sawyer","year":"2000","journal-title":"Antiviral Res."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2004.05.020_BIB37","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1399-3062.2001.00010.x","article-title":"Use of cytomegalovirus immune globulin and ganciclovir for the prevention of cytomegalovirus disease in lung transplantation","volume":"3","author":"Zamora","year":"2001","journal-title":"Transpl. Infect. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2004.05.020_BIB38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1034\/j.1399-3062.2001.00007.x","article-title":"Cytomegalovirus prophylaxis with ganciclovir and cytomegalovirus immune globulin in liver and intestinal transplantation","volume":"3","author":"Tzakis","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.05.020_BIB39","first-page":"17","article-title":"Meta-analysis of CMVIG studies for the prevention and treatment of CMV infection in transplant patients","volume":"28","author":"Wittes","year":"1996","journal-title":"Transplant Proc."},{"issue":"Suppl. 2","key":"10.1016\/j.intimp.2004.05.020_BIB40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1034\/j.1399-3062.2001.00002.x","article-title":"Historical overview of the use of cytomegalovirus hyperimmune globulin in organ transplantation","volume":"3","author":"Snydman","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.05.020_BIB41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00001573-199803000-00009","article-title":"Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients","volume":"13","author":"Avery","year":"1998","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bmt.1700649","article-title":"No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group","volume":"19","author":"Ruutu","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.intimp.2004.05.020_BIB43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/viro.1993.1575","article-title":"Glycoprotein B of human cytomegalovirus promotes virion penetration into cells, transmission of infection from cell to cell, and fusion of infected cells","volume":"197","author":"Navarro","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2004.05.020_BIB44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1083-8791(01)80005-7","article-title":"Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Boeckh","year":"2001","journal-title":"Biol. Blood Marrow Transplant"},{"key":"10.1016\/j.intimp.2004.05.020_BIB45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4757-9209-6_15","article-title":"Immunotherapy of CMV infections","volume":"394","author":"Paar","year":"1996","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB46","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1086\/514040","article-title":"A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections","volume":"176","author":"Hamilton","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.05.020_BIB47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1089\/vim.2000.13.49","article-title":"Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin","volume":"13","author":"Drulak","year":"2000","journal-title":"Viral Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB48","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1056\/NEJM199105023241804","article-title":"Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor","volume":"324","author":"Brown","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB49","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0264-410X(99)00567-8","article-title":"Antibody responses, cytokine levels and protection of mice immunised with HSV-2 antigens formulated into NISV or ISCOM delivery systems","volume":"18","author":"Mohamedi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.intimp.2004.05.020_BIB50","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08830180305228","article-title":"Vaginal immunity in the HSV-2 mouse model","volume":"22","author":"Parr","year":"2003","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB51","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1056\/NEJMoa011915","article-title":"Glycoprotein-D-adjuvant vaccine to prevent genital herpes","volume":"347","author":"Stanberry","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/CMR.16.1.96-113.2003","article-title":"Recent progress in herpes simplex virus immunobiology and vaccine research","volume":"16","author":"Koelle","year":"2003","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.intimp.2004.05.020_BIB53","first-page":"896","article-title":"Life-threatening complications of varicella","volume":"135","author":"Fleisher","year":"1981","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.intimp.2004.05.020_BIB54","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM197401312900503","article-title":"Zoster immune globulin. A further assessment","volume":"290","author":"Gershon","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB55","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/160.3.535","article-title":"Herpes zoster in an adult recipient of live attenuated varicella vaccine","volume":"160","author":"Hammerschlag","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.05.020_BIB56","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/infdis\/159.5.1000","article-title":"Zoster in normal children after varicella vaccine","volume":"159","author":"Plotkin","year":"1989","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.05.020_BIB57","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination","volume":"347","author":"Galil","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB58","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group","volume":"325","author":"Hardy","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB59","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.18.1.739","article-title":"Multiple roles for the major histocompatibility complex class I-related receptor FcRn","volume":"18","author":"Ghetie","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB60","doi-asserted-by":"crossref","first-page":"9772","DOI":"10.1073\/pnas.171308498","article-title":"Identification of a family of Fc receptor homologs with preferential B cell expression","volume":"98","author":"Davis","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2004.05.020_BIB61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.iy.06.040188.002121","article-title":"The immunoglobulin superfamily-domains for cell surface recognition","volume":"6","author":"Williams","year":"1988","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.19.1.275","article-title":"IgG Fc receptors","volume":"19","author":"Ravetch","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB63","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.4049\/jimmunol.147.6.1863","article-title":"Chimeric Fc receptors identify functional domains of the murine high affinity receptor for IgG","volume":"147","author":"Hulett","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB64","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s002770050396","article-title":"The IgG Fc receptor family","volume":"76","author":"Gessner","year":"1998","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/264415a0","article-title":"Crystallographic structure studies of an IgG molecule and an Fc fragment","volume":"264","author":"Huber","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2004.05.020_BIB66","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/35018508","article-title":"The 3.2-A crystal structure of the human IgG1 Fc fragment\u2013Fc gammaRIII complex","volume":"406","author":"Sondermann","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2004.05.020_BIB67","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/8241","article-title":"Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa","volume":"6","author":"Maxwell","year":"1999","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB68","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/35018500","article-title":"Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI alpha","volume":"406","author":"Garman","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2004.05.020_BIB69","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.4049\/jimmunol.152.3.1314","article-title":"Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16","volume":"152","author":"Bazil","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB70","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/intimm\/5.8.859","article-title":"Identification, in mouse macrophages and in serum, of a soluble receptor for the Fc portion of IgG (Fc gamma R) encoded by an alternatively spliced transcript of the Fc gamma RII gene","volume":"5","author":"Tartour","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB71","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0092-8674(94)90115-5","article-title":"FcR gamma chain deletion results in pleiotrophic effector cell defects","volume":"76","author":"Takai","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2004.05.020_BIB72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1074-7613(00)80494-X","article-title":"Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice","volume":"5","author":"Hazenbos","year":"1996","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2004.05.020_BIB73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1084\/jem.189.1.187","article-title":"Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis","volume":"189","author":"Yuasa","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.191.5.899","article-title":"Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease","volume":"191","author":"Nakamura","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0065-2776(08)60722-1","article-title":"Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumonococci","volume":"32","author":"Langone","year":"1982","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB76","first-page":"73","article-title":"Interaction of streptococci with the Fc fragment of IgG","volume":"84","author":"Christensen","year":"1976","journal-title":"Acta Pathol. Microbiol. Scand., C"},{"key":"10.1016\/j.intimp.2004.05.020_BIB77","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1084\/jem.154.6.1732","article-title":"Receptor for immunoglobulin Fc on pathogenic but not on nonpathogenic protozoa of the Trypanosomatidae","volume":"154","author":"De Miranda-Santos","year":"1981","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2004.05.020_BIB78","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/278447a0","article-title":"Receptor for IgG(Fc) and human beta2-microglobulin on S. mansoni schistosomula","volume":"278","author":"Torpier","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2004.05.020_BIB79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-4684-5823-7_8","article-title":"Fc receptor-like activity of mouse hepatitis virus E2 glycoprotein","volume":"276","author":"Oleszak","year":"1990","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB80","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1074\/jbc.M311470200","article-title":"Fcgamma receptor-like activity of hepatitis C virus core protein","volume":"279","author":"Maillard","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2004.05.020_BIB81","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000150065","article-title":"Induction of Fc (IgG) receptor(s) by simian cytomegaloviruses in human embryonic lung fibroblasts","volume":"29","author":"Eizuru","year":"1988","journal-title":"Intervirology"},{"key":"10.1016\/j.intimp.2004.05.020_BIB82","doi-asserted-by":"crossref","first-page":"7757","DOI":"10.1128\/JVI.68.12.7757-7765.1994","article-title":"Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor","volume":"68","author":"Thale","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB83","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1128\/JVI.76.17.8596-8608.2002","article-title":"Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs","volume":"76","author":"Atalay","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/JVI.41.1.137-144.1982","article-title":"Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein","volume":"41","author":"Para","year":"1982","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB85","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0042-6822(90)90402-D","article-title":"Cell surface expression of the varicella-zoster virus glycoproteins and Fc receptor","volume":"178","author":"Litwin","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2004.05.020_BIB86","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1099\/vir.0.18663-0","article-title":"Antibody-induced internalization of viral glycoproteins and gE\u2013gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis","volume":"84","author":"Van de Walle","year":"2003","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB87","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0168-1702(98)00110-5","article-title":"The genetic organization and transcriptional analysis of the short unique region in the genome of nononcogenic Marek's disease virus serotype 2","volume":"58","author":"Jang","year":"1998","journal-title":"Virus Res."},{"key":"10.1016\/j.intimp.2004.05.020_BIB88","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/JVI.32.3.779-789.1979","article-title":"Membrane proteins specified by herpes simplex viruses: V. Identification of an Fc-binding glycoprotein","volume":"32","author":"Baucke","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB89","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1128\/JVI.62.4.1347-1354.1988","article-title":"Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI","volume":"62","author":"Johnson","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB90","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1128\/JVI.66.6.3643-3651.1992","article-title":"Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI","volume":"66","author":"Litwin","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/JVI.60.1.185-193.1986","article-title":"Use of lambda gt11 to isolate genes for two pseudorabies virus glycoproteins with homology to herpes simplex virus and varicella-zoster virus glycoproteins","volume":"60","author":"Petrovskis","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB92","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1128\/JVI.68.4.2478-2485.1994","article-title":"Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates","volume":"68","author":"Dubin","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB93","doi-asserted-by":"crossref","first-page":"6911","DOI":"10.1074\/jbc.274.11.6911","article-title":"Characterization of the interaction between the herpes simplex virus type I Fc receptor and immunoglobulin G","volume":"274","author":"Chapman","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2004.05.020_BIB94","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1128\/JVI.72.7.5351-5359.1998","article-title":"In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor","volume":"72","author":"Nagashunmugam","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB95","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/JVI.68.2.834-845.1994","article-title":"Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells","volume":"68","author":"Dingwell","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB96","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1128\/JVI.63.11.4479-4488.1989","article-title":"A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G","volume":"63","author":"Frank","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB97","first-page":"109","article-title":"Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells","volume":"77","author":"Van Vliet","year":"1992","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2004.05.020_BIB98","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1021\/bi00148a004","article-title":"Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors","volume":"31","author":"Zheng","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.intimp.2004.05.020_BIB99","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1128\/JVI.71.5.4042-4054.1997","article-title":"Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail","volume":"71","author":"Olson","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB100","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1128\/JVI.65.6.3411-3415.1991","article-title":"An Fc receptor for human immunoglobulin G is located within the tegument of human cytomegalovirus","volume":"65","author":"Stannard","year":"1991","journal-title":"J. Virol."},{"issue":"Pt 4","key":"10.1016\/j.intimp.2004.05.020_BIB101","first-page":"893","article-title":"Characterization of IgG Fc receptors induced by human cytomegalovirus","volume":"70","author":"Xu","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB102","doi-asserted-by":"crossref","first-page":"11218","DOI":"10.1128\/JVI.75.22.11218-11221.2001","article-title":"Human cytomegalovirus open reading frame TRL11\/IRL11 encodes an immunoglobulin G Fc-binding protein","volume":"75","author":"Lilley","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB103","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1006\/jmbi.2001.4670","article-title":"Molecular basis for immune complex recognition: a comparison of Fc-receptor structures","volume":"309","author":"Sondermann","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB104","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/372336a0","article-title":"Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor","volume":"372","author":"Burmeister","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2004.05.020_BIB105","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0092-8674(92)90636-Q","article-title":"A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains","volume":"69","author":"Letourneur","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2004.05.020_BIB106","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1099\/0022-1317-82-5-1137","article-title":"Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus","volume":"82","author":"Antonsson","year":"2001","journal-title":"J. Gen. Virol."},{"issue":"Pt 7","key":"10.1016\/j.intimp.2004.05.020_BIB107","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1099\/0022-1317-67-7-1475","article-title":"Fc receptor(s) induced by human cytomegalovirus bind differentially with human immunoglobulin G subclasses","volume":"67","author":"Murayama","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB108","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1128\/JVI.77.10.5749-5758.2003","article-title":"Direct relationship between suppression of virus-specific immunity and emergence of cytomegalovirus disease in simian AIDS","volume":"77","author":"Kaur","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB109","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/343659a0","article-title":"HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor","volume":"343","author":"McKeating","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2004.05.020_BIB110","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1128\/JVI.74.16.7656-7665.2000","article-title":"Complete DNA sequence of the rat cytomegalovirus genome","volume":"74","author":"Vink","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB111","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0042-6822(88)90155-9","article-title":"Molecular cloning and mapping of rat cytomegalovirus DNA","volume":"166","author":"Burns","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2004.05.020_BIB112","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/viro.1998.9196","article-title":"The Maastricht strain and England strain of rat cytomegalovirus represent different betaherpesvirus species rather than strains","volume":"246","author":"Beisser","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2004.05.020_BIB113","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/JVI.72.2.1377-1382.1998","article-title":"Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control","volume":"72","author":"Crnkovic-Mertens","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB114","doi-asserted-by":"crossref","first-page":"6292","DOI":"10.1128\/JVI.75.14.6292-6302.2001","article-title":"Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen","volume":"75","author":"Hanson","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB115","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nbt1202-1189","article-title":"Antibody evolution beyond Nature","volume":"20","author":"Borrebaeck","year":"2002","journal-title":"Nat. Biotechnol."},{"issue":"Pt. 1","key":"10.1016\/j.intimp.2004.05.020_BIB116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1099\/0022-1317-72-1-149","article-title":"Protection against murine cytomegalovirus infection by passive transfer of neutralizing and non-neutralizing monoclonal antibodies","volume":"72","author":"Farrell","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB117","first-page":"57","article-title":"Effector mechanisms activated by human IgG subclass antibodies: clinical and molecular aspects. Review article","volume":"52","author":"Jefferis","year":"1994","journal-title":"Ann. Biol. Clin. (Paris)"},{"key":"10.1016\/j.intimp.2004.05.020_BIB118","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1042\/bst0300495","article-title":"The contrasting IgG-binding interactions of human and herpes simplex virus Fc receptors","volume":"30","author":"Armour","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.intimp.2004.05.020_BIB119","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/JVI.64.3.1079-1085.1990","article-title":"Cell surface expression of human cytomegalovirus (HCMV) gp55\u2013116 (gB): use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response","volume":"64","author":"Britt","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB120","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1128\/JVI.66.3.1303-1311.1992","article-title":"The dominant linear neutralizing antibody-binding site of glycoprotein gp86 of human cytomegalovirus is strain specific","volume":"66","author":"Urban","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.intimp.2004.05.020_BIB121","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/JVI.73.2.878-886.1999","article-title":"Strain-specific neutralization of human cytomegalovirus isolates by human sera","volume":"73","author":"Klein","year":"1999","journal-title":"J. Virol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904001766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904001766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T21:47:43Z","timestamp":1682718463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576904001766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":121,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S1567576904001766"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2004.05.020","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}